top of page

enGenes brings hi-tech biological production leadership to BioProcess International Vienna

  • Writer: Juergen Mairhofer
    Juergen Mairhofer
  • 4 days ago
  • 1 min read

Vienna, Austria: – High-yield end-to-end bioprocessing specialist CDMO enGenes Biotech will be present at the upcoming BioProcess International (BPI) European conference in Vienna in late April 2026.

enGenes Business Development Manager Ophelia Gevaert will represent enGenes at the conference to communicate the CDMO’s distinctive offers, technologies and capabilities in high end production of  recombinant proteins, plasmid DNA, vaccines, antibodies, and peptides.

Proprietary platforms

Ms. Gevaert will also be able to show the benefits of proprietary enGenes technology platforms for advanced biomolecule production. These include:

  • enGenes -eXpress™ as an optimized solution for the cost-effective production of recombinant protein and plasmid DNA in microbial expression systems

  • enGenes -eXcess™ for enhanced yield decoupled recombinant proteins production in coli

  • enGenes -eXchange™ for antibiotic-free and resistance marker-free manufacturing of recombinant proteins and high-quality plasmid DNA

  • enGenes -eXrase™ next-generation recombinant endonuclease for powerful DNA/RNA digestion at a fraction of the cost of traditional market enzymes

  • enGenes -eXcite™ as a cutting-edge technology that further supports continuous manufacturing of biomolecules in coli by enabling high yields and scalability from a very small footprint



 
 
 

Comments

bottom of page